The use of biological agents and immunomodulators for inflammatory bowel disease (IBD) is associated with an increased risk of opportunistic infections, in particular of viral or bacterial etiology. Despite the existence of international guidelines, many gastroenterologists have not adopted routine screening and vaccination in those patients with IBD, which are candidate for biologic therapy. Available strategies to screen, diagnose and prevent bacterial and viral infections in patients with IBD prior to start biological therapy are discussed in this review

Andrisani, G., Armuzzi, A., Marzo, M., Felice, C., Pugliese, D., Papa, A., Guidi, L., What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?, <<WORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS>>, 2016; 7 (3): 387-396. [doi:10.4292/wjgpt.v7.i3.387] [http://hdl.handle.net/10807/93029]

What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?

Andrisani, Gianluca
Primo
;
Armuzzi, Alessandro
Secondo
;
Marzo, Manuela;Felice, Carla;Pugliese, Daniela;Papa, Alfredo
Penultimo
;
Guidi, Luisa
2016

Abstract

The use of biological agents and immunomodulators for inflammatory bowel disease (IBD) is associated with an increased risk of opportunistic infections, in particular of viral or bacterial etiology. Despite the existence of international guidelines, many gastroenterologists have not adopted routine screening and vaccination in those patients with IBD, which are candidate for biologic therapy. Available strategies to screen, diagnose and prevent bacterial and viral infections in patients with IBD prior to start biological therapy are discussed in this review
Inglese
Andrisani, G., Armuzzi, A., Marzo, M., Felice, C., Pugliese, D., Papa, A., Guidi, L., What is the best way to manage screening for infections and vaccination of inflammatory bowel disease patients?, <<WORLD JOURNAL OF GASTROINTESTINAL PHARMACOLOGY AND THERAPEUTICS>>, 2016; 7 (3): 387-396. [doi:10.4292/wjgpt.v7.i3.387] [http://hdl.handle.net/10807/93029]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/93029
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact